Join
Live feed
·
PRReleasevia Quantisnow
Revvity Inc. logo

Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery

ByQuantisnow·Wall Street's wire, on your screen.
RVTY· Revvity Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVTY (Revvity Inc.) and more on Quantisnow.